Acceleration of Fetal Lung Maturation for Women at Risk of Preterm Delivery | Obstetrics

Skip to content

Select language English

Antenatal betamethasone for women at risk for late preterm delivery. (opens new window)

Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, Rouse DJ, McKenna DS, Clark EA, et al

Source‎: N Engl J Med. 2016;374(14):1311-20.

Indexed‎: PubMed 26842679

DOI‎: 10.1056/NEJMoa1516783

https://pubmed.ncbi.nlm.nih.gov/26842679/ (opens new window)

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. (opens new window)

McGoldrick E, Stewart F, Parker R, Dalziel SR

Source‎: Cochrane Database Syst Rev 2020;12(12):CD004454.

Indexed‎: PubMed 33368142

DOI‎: 10.1002/14651858.CD004454.pub4

https://pubmed.ncbi.nlm.nih.gov/33368142/ (opens new window)

Antenatal corticosteroid therapy before 24 weeks of gestation: a systematic review and meta-analysis. (opens new window)

Park CK, Isayama T, McDonald SD

Source‎: Obstet Gynecol 2016;127(4):715-25.

Indexed‎: PubMed 26959200

DOI‎: 10.1097/AOG.0000000000001355

https://pubmed.ncbi.nlm.nih.gov/26959200/ (opens new window)

Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. (opens new window)

Walters A, McKinlay C, Middleton P, Harding JE, Crowther CA

Source‎: Cochrane Database Syst Rev 2022;4(4):CD003935.

Indexed‎: PubMed 35377461

DOI‎: 10.1002/14651858.CD003935.pub5

https://pubmed.ncbi.nlm.nih.gov/35377461/ (opens new window)

Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth. (opens new window)

Williams MJ, Ramson JA, Brownfoot FC

Source‎: Cochrane Database Syst Rev 2022;8(8):CD006764.

Indexed‎: PubMed 35943347

DOI‎: 10.1002/14651858.CD006764.pub4

https://pubmed.ncbi.nlm.nih.gov/35943347/ (opens new window)

OBSTETRICS

Acceleration of Fetal Lung Maturation for Women at Risk of Preterm Delivery

English

Acceleration of Fetal Lung Maturation for Women at Risk of Preterm Delivery

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Hospital Liaison Committee (HLC)

Contact local representatives who provide free assistance to clinicians treating Jehovah’s Witnesses.

Medical Information Packets

Subjects include: Clinical strategies for managing hemorrhage and anemia without blood transfusion, the religious and ethical position of Jehovah’s Witnesses on medical therapy, and the services Witnesses offer to the medical community through their worldwide network of Hospital Liaison Committees.

Videos

Treatment options as well as medical and ethical considerations for clinicians who treat Jehovah’s Witnesses.

The medical section of jw.org is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.

Copied

Share Via Email